Accelerating Medicinal Chemistry Cycle Times Through Cloud-Accessible Smart Automated Labs

To advance a lead candidate through to clinical trials in traditional small molecule pipelines, it can take on average 6+ years. Iterative cycles of design, make, test and analyze (DMTA) are at the core of early stage drug discovery. Medicinal chemistry is a critical component within small molecule drug discovery and involves the design of molecules, synthesis, testing via bioassays, and analysis of results; however, bottlenecks, such as highly manual, time-intensive procedures (i.e., synthesizing and purifying compounds), whether in-house or outsourced, as well as non-standardized analog data capture lead to slow cycle times. Strateos’ goal is to automate many of the operations to enable a chemist to work on multiple programs at the same time in parallel, greatly improving the process efficiencies and shortening cycle times.

In this presentation, you will learn: 

• 
  

  The capabilities of Strateos’s 23 drug discovery automation modules, and how they can be accessed via the cloud from anywhere in the world
  



• 
  

  Synergies enabled by full integration under the Strateos cloud-based software stack
  



• 
  

  Lessons learned from over a year operating in production mode